Learning Outcomes
Development of the ability to recognise und understand the main interpretative issues related to the taught provisions, to use appropriate interpretative methods for solving them, to present und critically evaluate the opinions supported about them in science and jurisprudence and to apply correctly the provisions in the framework of practical exercises.
Course Content (Syllabus)
In this course, all the procedures for granting drug marketing authorizations, at national and European level, are presented and analyzed. Specifically, the Circular no. 38889/11-06-2008, the referred to the control procedure of compliance with the essential conditions for acquiring and maintaining the status of marketing authorization holder of medicinal products intended for human use, as well as the relevant competence of the E.O.F. At the same time, the procedure for obtaining the so-called European marketing authorization, which is provided for by Regulation no. 726/2004 (L 136/30.4.2004 p. 1-33), as well as the authorization at European level for other categories of medicines, such as for orphan medicines. The course also examines all the obligations of marketing authorization holders, as well as the responsibilities of committees that assist in the granting of licenses and the classification of medicines, such as the Evaluation Committee of Law 4512/2018.
Keywords
types of permits, conditions and procedure for granting them, indications and conditions of circulation
Additional bibliography for study
Επιπρόσθετη βιβλιογραφία καθώς και άλλο βοηθητικό υλικό (διαγράμματα παραδόσεων, πρακτικά παραδόσεων, αποφάσεις νομολογίας, φροντιστηριακές ασκήσεις, σεμιναριακό υλικό) παρέχεται κατά τη διάρκεια των μαθημάτων από τον εκάστοτε διδάσκοντα / διδάσκουσα ή αναρτάται στο e-learning.